Trial intelligence / Profile preview

Dexmedetomidine vs Clonidine for Delirium in CABG

NCT03477994Completed

Sponsor
Ain Shams University
Start
Dec 2018
Primary completion
Feb 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of dexmedetomidine in delirium (2 arms), sponsored by Ain Shams University. Primary endpoint: Incidence of Delirium at 5 days. Started Dec 2018; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

delirium

Beyond the preview

Go deeper on NCT03477994.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03477994.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call